December 3, 2004
It is the first approval in the United States of a generic antiretroviral product to treat HIV/AIDS.
Didanosine (ddI) is a generic version of the already approved Videx EC Delayed-Release Capsules manufactured by Bristol Myers Squibb. It is a delayed-release capsule, taken once daily.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.